Trials / Unknown
UnknownNCT00380172
Long-Term Efficacy in AMD of Rheopheresis in North America
A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- OccuLogix · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of these studies are to evaluate the effect on vision in subjects with AMD who received active and placebo treatment in the MIRA-1 study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rheopheresis blood filtration |
Timeline
- Start date
- 2005-10-01
- Completion
- 2007-10-01
- First posted
- 2006-09-25
- Last updated
- 2006-09-25
Locations
9 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00380172. Inclusion in this directory is not an endorsement.